NRGene Technologies Ltd

NRGene Technologies Ltd

NRGN.TA
NRGene Technologies LtdIL flagTel Aviv Stock Exchange
202.20
ILA
- -
- -
26.83MMarket Cap
NRGene Technologies Ltd
NRGN.TA
(Tel Aviv Stock Exchange)

Recent

price

202.20

P/E

ratio

- -

div

yld

- -

ROIC.AI

2020
2021
2022
2023
2024
2025
FRC
0.57
0.37
0.25
0.16
0.1
- -
Revenue per Share
-0.26
-0.69
-0.5
-0.42
-0.26
- -
Basic EPS, GAAP
-0.12
-0.55
-0.51
-0.32
-0.29
- -
Free Cash Flow per Basic Share
- -
- -
- -
- -
- -
- -
Dividend per Share
-2.46
-3.19
-3.59
-3.98
-4.2
- -
Book Value per Share
-0.45
1.41
0.84
0.39
0.05
- -
Tangible Book Value per Share
12
12
12
13
13
- -
Basic Weighted Avg Shares
7
4
3
2
1
3
Sales/Revenue/Turnover
-24.41
-188.26
-173.85
-263.87
-345.35
-49.53
Operating Margin (%)
- -
- -
- -
1
1
1
Depreciation Expense
-3
-8
-6
-5
-3
-2
Net Income, GAAP
- -
- -
- -
- -
- -
- -
Effective Tax Rate (%)
-44.72
-186.83
-196.49
-262.02
-260.39
-47.38
Profit Margin (%)
-4
17
10
4
- -
1
Working Capital
1
1
- -
1
- -
- -
LT Debt
-6
18
12
7
4
4
Total Equity
- -
- -
- -
- -
- -
- -
Return on Invested Capital (%)
- -
- -
- -
- -
- -
- -
Return on Capital (%)
- -
- -
- -
- -
- -
- -
Return on Common Equity (%)

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.

(avg. rate of change)

10 years
5 years
1 year
Total Equity
- -
-105.18%
10.31%
Free Cash Flow
- -
38.43%
-119.91%
Net Income, GAAP
- -
6.55%
-55.28%
Sales/Revenue/Turnover
- -
1.55%
145.74%
Total Cash Common Dividend
- -
- -
- -

Quarterly Revenue

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
2
2024
- -
- -
- -
- -
1
2025
- -
- -
- -
- -
3

Quarterly Earnings Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
-0.42
2024
- -
- -
- -
- -
-0.26
2025
- -
- -
- -
- -
- -

Quarterly Dividends Per Share

FRC

in mil. unless spec.

Year

Q1
Q2
Q3
Q4
FY
2023
- -
- -
- -
- -
- -
2024
- -
- -
- -
- -
- -
2025
- -
- -
- -
- -
- -
Business
NRGene Technologies Ltd (NRGN.TA) is an Israel-based AgTech company specializing in AI-driven genomics for accelerating and improving the natural breeding of crops and animals in the global agriculture and food industries. Founded in 2009 and headquartered in Ness Ziona, the company develops advanced computational tools, proprietary algorithms, and software platforms including GenoMAGIC, TraitMAGIC, SnPer, SnPro, Soy SNPro, and Canola Pro; it offers customized genotyping solutions, genome assemblies, genomic mapping, diversity analysis, trait mapping, prediction services, and turnkey solutions for breeding programs targeting key crops such as wheat, canola, corn, soybean, maize, tomatoes, strawberries, legumes, peanuts, stevia, and cannabis, as well as animals and insects like black soldier fly. NRGene serves leading breeding companies, AgTech and food-tech firms, academia, research institutes, and agribiotech entities worldwide across North America, Europe, the Middle East, Africa, Asia Pacific, with subsidiaries in the United States, Canada, and Germany, including a genotyping lab in Saskatoon; its vast proprietary database supports over 300 completed projects, enhancing sustainable food production by improving crop resilience, water efficiency, nutritional profiles, yield, shelf life, and reducing environmental footprints. Recent developments include a 2023 asset purchase agreement with Above Food Corp. for AI-based genomic assets, intellectual property, and trait technology licensing rights including clubroot-resistant canola germplasm, high-protein traits, and DNA markers, with NRGene Canada R&D team integration pending Above Food's business combination completion; strategic collaborations with Bühler for black soldier fly genetics and processing, Top Seeds International (Mitsui & Co.), Granot Group for vertical farming varieties, and ongoing advancements like ToBRFV trait mapping in tomatoes and non-allergenic wheat and peanuts. The company listed on the Tel Aviv Stock Exchange via IPO and maintains global operations focused on IP-intensive trait and variety commercialization.